Montag & Associates’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,000
| Closed | -$54K | – | 1038 |
|
|
2025
Q1 | $54K | Hold |
3,000
| – | – | ﹤0.01% | 601 |
|
|
2024
Q4 | $52.4K | Hold |
3,000
| – | – | ﹤0.01% | 603 |
|
|
2024
Q3 | $34.5K | Hold |
3,000
| – | – | ﹤0.01% | 660 |
|
|
2024
Q2 | $34K | Hold |
3,000
| – | – | ﹤0.01% | 644 |
|
|
2024
Q1 | $43K | Hold |
3,000
| – | – | ﹤0.01% | 619 |
|
|
2023
Q4 | $41.1K | Hold |
3,000
| – | – | ﹤0.01% | 612 |
|
|
2023
Q3 | $24.4K | Hold |
3,000
| – | – | ﹤0.01% | 649 |
|
|
2023
Q2 | $22.7K | Hold |
3,000
| – | – | ﹤0.01% | 664 |
|
|
2023
Q1 | $24K | Hold |
3,000
| – | – | ﹤0.01% | 652 |
|
|
2022
Q4 | $34.1K | Hold |
3,000
| – | – | ﹤0.01% | 603 |
|
|
2022
Q3 | $26K | Hold |
3,000
| – | – | ﹤0.01% | 630 |
|
|
2022
Q2 | $30K | Buy |
+3,000
| New | +$30.2K | ﹤0.01% | 605 |
|
|
2021
Q4 | – | Sell |
-1,802
| Closed | -$23K | – | 920 |
|
|
2021
Q3 | $23K | Hold |
1,802
| – | – | ﹤0.01% | 659 |
|
|
2021
Q2 | $27K | Hold |
1,802
| – | – | ﹤0.01% | 634 |
|
|
2021
Q1 | $25K | Hold |
1,802
| – | – | ﹤0.01% | 639 |
|
|
2020
Q4 | $33K | Buy |
+1,802
| New | +$27.8K | ﹤0.01% | 585 |
|
Montag & Associates's PTVE Position: Q2 2025 in Review
Montag & Associates sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q2 2025, closing a stake of 3,000 shares — an estimated $54K sold.
Montag & Associates first reported a position in PTVE in Q4 2020 and held it in 16 quarters. The position peaked at $54K in Q1 2025. 0 funds tracked by Wall St. Rank hold PTVE as of Q2 2025.
- Montag & Associates reported no remaining Pactiv Evergreen Inc. Common stock position as of Q2 2025 after selling out during the quarter.
- Montag & Associates sold 3,000 Pactiv Evergreen Inc. Common stock shares in Q2 2025, an estimated $54K.
- Montag & Associates first reported a position in Pactiv Evergreen Inc. Common stock in Q4 2020 and held it in 16 quarters.
- Montag & Associates's Pactiv Evergreen Inc. Common stock position peaked at $54K in Q1 2025.
- 0 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q2 2025.
Based on Montag & Associates's 13F filing for Q2 2025, filed 7 Aug 2025.